Complicated urinary tract infections (UTIs) occur frequently in patients after kidney transplantation due to suppression of the immune system and may lead to transplant failure or sepsis. Detecting the source and extent of infection—especially whether the transplanted kidney (allograft) is involved—without further invasive procedures can be challenging.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
“Direct visualization of infiltrating leukocytes in renal allografts in the context of kidney infection has not been done before using PET,” explains Thorsten Derlin, MD, Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany. “Other imaging methods have not been very useful in the past for diagnosing renal infection, and biopsy may have complications, including bleeding.”
For the study, 13 kidney transplant recipients with complicated UTIs underwent PET with the CXCR4-ligand 68Ga-Pentixafor and diffusion-weighted MRI. The combined PET/MRI detected acute infection in the transplanted kidneys of 9 patients and lower UTI/non-urological infections in the remaining 4 patients.
Combined CXCR4-targeted PET/MR imaging with 68Ga-Pentixafor, therefore, shows strong potential for noninvasive detection of leukocytes in kidney transplants. This novel methodology may also refine the characterization of infectious and inflammatory kidney diseases and may serve as a platform for future clinical studies targeting transplanted tissue (allograft) infection.
“This work establishes CXCR4-targeted PET as a novel approach for imaging of infection, and it strengthens the role of nuclear medicine for renal imaging,” Derlin states. “It demonstrates the potential of integrating state-of-the art imaging approaches—i.e., diffusion-weighted MRI and novel, highly specific PET tracers—for a comprehensive assessment of kidney disease and has the potential to be translated into other settings of difficult-to-diagnose infections, such as cholangitis in transplanted patients and bone infections.”Figure: Renal leukocyte infiltration in PET and MR imaging.
MR imaging showing focal restriction of diffusion (A, red arrows). Biopsy from a kidney allograft shows inflammatory cell infiltration typical for allograft infection (granulocytes (CD15, B), and T cells (CD3, C). Corresponding upregulated CXCR4 expression (D, white arrows). Additional markers of cell infiltration (B cells [CD20, E] and macrophages [CD68, F]). Scale bar indicates 200 μm. Credit: T Derlin et al., Hannover Medical School, Hannover, Germany.
Authors of “Integrating MRI and chemokine receptor CXCR4-targeted PET for detection of leukocyte infiltration in complicated urinary tract infections after kidney transplantation” include Thorsten Derlin, Faikah Gueler, Jan Hinrich Bräsen, Jessica Schmitz, Dagmar Hartung, Thomas R. Herrmann, Tobias L. Ross, Frank Wacker, Marcus Hiss, Hermann Haller, Frank M. Bengel, and Katja Hueper at Hannover Medical School, Hannover, Germany, and Hans-Jürgen Wester at Technical University, Munich, Germany.